Faron Pharmaceuticals Oy (LSE:FARN) - Share price


Stock Report

Faron Pharmaceuticals Oy FARN

Last Price
GBX130.00

Day Change
-7.00|-5.11%

As of 18/10/2019
16:35:05 BST | GBX
Minimum 15 Minutes Delay.

Last Close137.00p
Day Range129.00 - 137.00
Mkt Cap32.86Mil
52-Wk Range50.04 - 167.97
Yield %-
ISINFI4000153309
Volume58,902
P/E-21.51
P/S1,300.00
P/CF-1.95

Share Price

Total Returns 18/10/2019

 Chg (%)  
More ...
Faron Pharmaceuticals Oy23.22 
FTSE 100 TR GBP-1.97
 
Financials
201620172018
More ...
Income Statement
Turnover0.950.000.02
Operating Profit-9.70-19.77-19.64
Net Profit-10.14-21.06-20.09
Reported EPS-0.42-0.76-0.65
Balance Sheet
Current Assets13.9513.236.83
Non Current Assets1.801.661.18
Total Assets15.7514.898.00
Current Liabilities4.658.065.75
Total Liabilities---
Total Equity8.404.740.37
Cash Flow
Operating Cash Flow-9.34-18.36-20.52
Net Change in Cash-0.22-1.88-5.28
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
29/03/2019PurchaseDr. Gregory B. Brown,M.D.60.0028,49017,094.00
29/03/2019PurchaseDr. Frank Murdoch Armstrong60.0033,33320,000.00
29/03/2019PurchaseMr. Matti Esa Manner60.0042,73525,641.00
29/03/2019PurchaseDr. Markku Tapani Jalkanen60.00284,900170,940.00

Company Profile

Faron Pharmaceuticals Oy is a clinical stage biopharmaceutical company developing novel treatments for medicalconditions. The company currently has a pipeline focusing on acute organ traumas,vascular damage and cancer immunotherapy.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 07/05/2020

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-884.49
Op Mrgn-1,033.74
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorDr. Gregory B. Brown,M.D.
Non-Executive Director, ChairmanDr. Frank Murdoch Armstrong
Non-Executive Director, Vice ChairmanMr. Matti Esa Manner
Non-Executive DirectorMr. Leopoldo Giampaolo Zambeletti
Executive Director, Chief Executive OfficerDr. Markku Tapani Jalkanen
Non-Executive DirectorMr. John Poulos
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.